Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22231,1714,1.11 [1.02-1.21],0.0189131174221895
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21766,4121,1.11 [1.05-1.17],0.0002288842272507
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21725,4220,1.09 [1.03-1.15],0.0027484192432422
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22235,1399,1.11 [1.01-1.22],0.0301638225651032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19740,1262,1.15 [1.04-1.27],0.008289006373905
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19072,1554,1.15 [1.05-1.26],0.0030294022269927
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14659,2690,1.08 [1.01-1.16],0.024965390107239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18507,483,1.24 [1.06-1.46],0.0079258225023964
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22489,1653,1.11 [1.01-1.21],0.0220490647369114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22532,1391,1.11 [1.01-1.23],0.0264531728290663
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22662,66,1.56 [1.06-2.29],0.0225362180766565
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22358,1217,1.14 [1.03-1.26],0.014028739541478
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22598,136,1.48 [1.12-1.96],0.0053637557248421
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22577,115,1.47 [1.08-1.99],0.0136260288192662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21007,490,1.19 [1.02-1.40],0.0294942401774657
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,20968,132,1.52 [1.15-2.01],0.0034706884113405
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,22374,259,0.75 [0.59-0.96],0.0215471570969051
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of meninges,22647,65,1.52 [1.03-2.25],0.0343893481312914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16187,69,2.82 [2.17-3.67],1.0603776117299476e-14
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16215,97,1.46 [1.04-2.05],0.0298549813193632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,16189,71,2.80 [2.16-3.63],8.092189256487903e-15
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of trunk,22635,76,1.60 [1.13-2.27],0.0087703129402406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16236,118,1.42 [1.04-1.94],0.02821242648912
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16314,196,1.58 [1.26-1.99],9.008389087408964e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16241,123,1.62 [1.22-2.17],0.0010190625958253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22368,381,1.27 [1.07-1.52],0.0071291275931179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20383,161,1.35 [1.03-1.76],0.030053084045497
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22054,67,1.64 [1.12-2.39],0.0107542993680305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21912,3423,1.13 [1.06-1.20],0.0001338684862266
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22155,1933,1.10 [1.01-1.19],0.0289592519804265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22154,1932,1.09 [1.01-1.19],0.0309810848827016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22308,1405,1.22 [1.11-1.34],2.883043268689129e-05
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22380,1391,1.14 [1.03-1.25],0.0081498131966539
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19051,1347,1.14 [1.04-1.26],0.0068802958931647
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15581,849,1.15 [1.01-1.30],0.030852815503426
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21037,6305,1.06 [1.01-1.11],0.0186962071120665
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21052,127,1.38 [1.03-1.86],0.0325021306880372
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21365,157,1.32 [1.01-1.73],0.0424600234284036
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,19826,80,1.43 [1.02-2.01],0.0377341939454063
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21834,2088,1.12 [1.03-1.21],0.0063558891647555
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21228,286,1.30 [1.07-1.59],0.0096297793444124
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiac arrest,8953,261,1.25 [1.01-1.56],0.0401905215023523
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22657,80,1.48 [1.03-2.14],0.0363568897261636
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,19386,7755,1.05 [1.01-1.09],0.0250695734682313
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19404,7773,1.05 [1.01-1.09],0.02367571867557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11836,205,1.34 [1.06-1.69],0.0150324288934575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22535,181,1.43 [1.12-1.82],0.0038039649814912
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21075,133,1.42 [1.07-1.89],0.0145267258048978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19350,1352,1.11 [1.00-1.22],0.0416995481839537
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,22136,4138,1.06 [1.00-1.12],0.0422404492954328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19416,1418,1.15 [1.05-1.26],0.0035416383506373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,22158,1154,1.14 [1.02-1.27],0.0239851932874653
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22645,69,1.66 [1.16-2.37],0.0051486166145302
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22652,82,1.66 [1.19-2.31],0.0029497310705398
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22643,73,1.74 [1.24-2.45],0.0014151968786613
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21122,163,1.44 [1.11-1.85],0.0056162423899502
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21484,149,0.72 [0.52-0.99],0.0408152799719262
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bronchiectasis,19014,506,1.19 [1.02-1.39],0.0292978713296689
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18578,70,1.71 [1.20-2.44],0.0028556695537209
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21560,3052,1.07 [1.01-1.15],0.0316310509476563
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20553,5981,1.06 [1.01-1.11],0.0120531865609074
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21401,438,1.23 [1.04-1.45],0.0131517698510993
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22407,2525,1.08 [1.01-1.16],0.0301986800691824
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,21442,479,1.28 [1.09-1.49],0.0019677498959479
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22378,1262,1.14 [1.03-1.26],0.0121855347187313
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22542,573,1.25 [1.08-1.45],0.002299779330713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22535,1680,1.11 [1.02-1.22],0.0148885458590864
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22124,2242,1.08 [1.00-1.17],0.0458240475492902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13940,69,1.62 [1.09-2.40],0.0179190260758063
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22356,1240,1.14 [1.03-1.26],0.0115402913302651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21952,1475,1.10 [1.00-1.21],0.0428694451312491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21623,773,1.19 [1.05-1.35],0.0056646342676661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21919,1069,1.12 [1.00-1.25],0.0412886402808001
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21796,946,1.13 [1.01-1.27],0.0369491396764498
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22322,312,1.30 [1.07-1.58],0.007138801425772
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22559,549,1.20 [1.03-1.39],0.0164686864167148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22309,299,1.30 [1.07-1.58],0.0093615287725897
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20318,333,0.81 [0.66-1.00],0.0458822225451967
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20313,328,1.24 [1.02-1.50],0.0283075797979218
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22400,65,1.55 [1.05-2.29],0.0287419708027236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19089,306,0.77 [0.62-0.96],0.0188327670540423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18725,80,1.56 [1.11-2.19],0.0108829843172562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22487,533,1.21 [1.05-1.41],0.0111204678276289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22647,60,1.58 [1.06-2.35],0.0259914390126884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22502,528,1.20 [1.03-1.39],0.0192608733125309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22632,69,1.77 [1.24-2.52],0.0016435101508303
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19059,276,0.78 [0.62-0.99],0.0380464476315162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16731,3066,1.09 [1.02-1.16],0.0071493096785054
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13726,61,1.54 [1.03-2.29],0.0338925126491391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14205,540,1.23 [1.07-1.43],0.0049276413400725
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22637,74,1.65 [1.16-2.36],0.0054610312102684
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21186,2212,1.12 [1.04-1.21],0.0029909678866068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21251,2277,1.10 [1.02-1.19],0.0147610963684494
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22430,130,1.69 [1.29-2.21],0.0001223641971302
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dialysis,19068,94,1.42 [1.00-2.02],0.0471986819219534
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11599,134,1.38 [1.04-1.83],0.0246049220382201
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22371,3672,1.10 [1.03-1.17],0.0020946853697242
